drugset / Trial / NCT00123604

Vascular Effects of Carvedilol Versus Metoprolol in Hypertensive Patients With Type 2 Diabetes

NCT00123604

Phase 4 Completed 36 enrolled St. Paul Heart Clinic GlaxoSmithKline · collab
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to compare the vascular effects of two commonly used blood pressure medications, carvedilol and metoprolol in hypertensive patients with type 2 diabetes.

Timeline

Start
2004-06
Primary completion
2006-06
Completion
2006-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Carvedilol Other / unclassified 25 mg Oral
Comparator Metoprolol Other / unclassified 200 mg Oral